In this podcast, Alexander Rothman, MD, PhD, discusses his team's latest analysis of CANTOS, which evaluated whether interleukin-1β inhibition would reduce blood pressure, prevent incident hypertension, and modify relationships between hypertension and cardiovascular events. More at: www.consultant360.com/cardiology.

In this podcast, Bill Kapogiannis, MD, discusses the multi-Federal agency SMILE Collaborative (Strategic Multisite Initiative for the Identification, Linkage and Engagement in Care of HIV-infected youth), which was an analysis of adolescents and young adults in the HIV care continuum in urban parts of the United States.

Dr Fleseriu discusses reproductive assistance options that can be pursued in patients with hypopituitarism who want to become pregnant, how endocrinologists can best navigate prescribing appropriate levels of pituitary hormone replacement therapy among pregnant patients, and more. For more, visit www.consultant360.com/endocrinology.

In this podcast, Ryan Tedford, MD, answers our questions about his team's latest study, which assessed the impact of the new definition of pulmonary hypertension (PH) on heart transplant outcomes. Pulmonary artery pressure and survival rates were evaluated. More at: www.consultant360.com/pulmonology or www.consultant360.com/cardiology

In this podcast, Timothy Amass, MD, answers our questions about his team's novel approach to reduce post-traumatic stress disorder (PTSD) and other stress-related issues for family members of patients in the intensive care unit (ICU). More at: www.consultant360.com/pulmonology.

In this podcast, Ryan Maddox, PhD, from the CDC, answers our questions about his team's latest study on the incidence of prion disease in the United States from 2003 to 2015, as well as discusses his other research in this area. More at: www.consultant360.com/infectious-diseases.

In this podcast, Thomas Holland, MD, from Rush University, answers our questions about his team's latest research on the effect of flavonols on the risk for Alzheimer dementia, as well as his other research in this area. More at: www.consultant360.com/neurology

In this podcast, Peter Libby, MD, gives an overview of clonal hematopoiesis of indeterminate potential, how it relates to cardiovascular medicine, and why it should be on your radar. More at: www.consultant360.com/cardiology

In this podcast, Rachana Kulkarni, MD, from the American Heart Association, answers our questions about managing CVD in women who are pregnant, the challenges she has experienced when managing these patients, and more. More at: www.consultant360.com/cardiology

In this podcast, Robert S. Rosenson, MD, from Mount Sinai Heart at the Icahn School of Medicine at Mount Sinai, discusses recent research about secondary prevention of atherosclerotic cardiovascular disease (ASCVD) and the implications of the research for clinical practice. More at: www.consultant360.com/cardiology